Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.
Published March 14, 2018 · Recall initiated: October 19, 2017
Summary
FDA records medical device Class II recall Z-0931-2018, published March 14, 2018 and initiated October 19, 2017. Recalling firm: Ion Beam Applications S.A.; Status: Terminated; Reported quantity: 3; Lot: PAT.003 (KR), PAT.006 (US). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Range for the same energy could be different depending if the layer is the first layer of the irradiation plan or not.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ion Beam Applications S.A.
- Distributor
- US Distribution to the state of :FL
- Lot
- PAT.003 (KR), PAT.006 (US)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Belgium
Related recalls
- FDAIBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10September 18, 2024
- FDAIBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment ofAugust 28, 2024
- FDAIBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment ofJune 12, 2024
- FDAIBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.May 1, 2024
- FDAmethylPREDNISolone Sodium Succinate for Injection, USP, 40 mg* per vial, Single-Dose Vial, Rx only, Mfd. for:March 21, 2018
- FDAAuriga XL 4007 Laser System, Universal Part Number: M0068FS4007G0. Intended to be used in surgical procedures.March 14, 2018
Questions about this recall
Was Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck. recalled?
Yes. FDA published recall Z-0931-2018 on March 14, 2018. Reported hazard: Range for the same energy could be different depending if the layer is the first layer of the irradiation plan or not.
What should I do if I have this product?
Voluntary: Firm initiated · Letter